GLP-1S (10mg)

Thryve Peptides
$99.95
Bulk Pricing:

Below are the available bulk discount rates for each individual item when you purchase a certain amount

  • Buy 2 - 2 and get 5% off
  • Buy 3 - 3 and get 10% off
  • Buy 4 - 4 and get 15% off
  • Buy 5 or above and get 20% off
(No reviews yet)
Current Stock:
Adding to cart… The item has been added

GLP-1S 10MG

COA Verified

Precision peptide research — focused on incretin pathway mechanisms.

  • GLP-1S is a long-acting synthetic peptide analog of GLP-1 (glucagon-like peptide-1), designed for research investigating metabolic regulation and glucose signaling.
  • Explored in laboratory studies for its influence on insulin secretion, energy balance, and appetite signaling pathways.
  • Independently tested and verified by Vanguard Laboratory for purity and identity.

For laboratory research use only. Not for human consumption.

Scientific Evidence

Semaglutide is a modified GLP-1 receptor agonist with enhanced half-life and receptor affinity. Research has focused on its dual impact on glucose-dependent insulin release and gastric emptying rate modulation.

Studies demonstrate that Semaglutide mimics endogenous GLP-1 actions through activation of cyclic AMP pathways in pancreatic β-cells (PubMed 27685622).

Investigations in metabolic and obesity models (SUSTAIN trials) confirm its potential relevance in long-term glycemic control research (PubMed 28931113).

Regulatory Status: Semaglutide is not FDA-approved for use outside regulated or clinical settings. This product is intended exclusively for research purposes.